Eli Lilly and Novo Nordisk win dismissal of antitrust suit by compound pharmacy
read at STAT ↗RegulatoryNeutral
A federal judge has thrown out an antitrust lawsuit filed by a compound pharmacy against Eli Lilly and Novo Nordisk. The decision clears the two companies of the alleged wrongdoing and removes a legal hurdle for their operations.
The column also notes that readers are being directed to coverage of Replimune's melanoma drug and a recent Medicare policy change, though no specific details are provided in the article.
Beyond the legal update, the piece includes the author's usual weekend reflections and reminders to stay engaged with industry news.
source
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Pharmalittle: We’re reading about Replimune’s melanoma drug, a Medicare policy change, and more”
read at STAT ↗760 words · retrieved Aug 7
comments(0)
5-min edit window · permanent after that